Opdivo - Drug Details
๐Ÿ“Š Estimates Opdivo Dialyzability By Different_Modalities

Opdivo

Complete Drug Information

Drug Name
Opdivo
Trade Names
Opdivo
Pregnancy Category
AU: D Use is not recommended
Routes of Administration
Intravenous
Elimination
27 days
Formula
C6362H9862N1712O1995S42
Molar Mass
143599.39
Drug Class
Immunotherapy
Volume of Distribution
C6362H9862N1712O1995S42

๐Ÿคฐ Pregnancy Category Information

Category: AU: D Use is not recommended

Drugs which have caused, are suspected to have caused, or may be expected to cause an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects.